Gynecomastia is fairly common. It is a physiologic phenomenon that occurs during puberty, when at least half of males experience enlargement of one or both breasts. Pubertal hypertrophy is characterized by a tender discoid enlargement of the breast tissue beneath the areola and usually subsides spontaneously within a year.
Gynecomastia also is common among elderly men, particularly...
Preventing deaths. Tamoxifen has long been hailed as a wonder drug for preventing recurrences of breast cancer. In the 1990s, studies... Read more »
Cancer Vixen (a.k.a. Marisa Acocella Marchetto), a fellow blogger here on MyBreastCancerNetwork.com recently wrote a post that left some of... Read more »
A recent post in our question and answer section brought to light an interesting and somewhat disturbing aspect of breast cancer and the... Read more »
Advisory: This week's post deals with sensitive sexual issues in a way that some readers may find graphic. This is your... Read more »
I wrote about CYP2D6, which refers to a gene that codes for a biologic molecule involved in the breakdown of tamoxifen, about a year ago. ... Read more »
Source: ADAM Encyclopedia
Gynecomastia is the development of abnormally large breasts in males. It is related to the excess growth of breast tissue, rather than excess fat... Read more »
Source: Breastcancer.org
Tamoxifen, the generic name of Nolvadex, is the oldest and most-prescribed SERM. Tamoxifen is approved by the U.S. Food and Drug Administration (FDA)... Read more »
Source: Breastcancer.org
Chemical name: Tamoxifen Brand names: Nolvadex, Apo-Tamox, Tamofen, Tamone Class: SERM (selective estrogen receptor modulator) hormonal therapy.... Read more »
Statistics show that many breast cancer survivors take antidepressants to help control the hot flashes brought on by the use of the drug tamoxifen, a... Read more »
A breast cancer patient asks Dr. Mitchell Hecht if her antidepressant will interfere with the drug tamoxifen. According to Dr. H, SSRI drugs like... Read more »